Page last updated: 2024-08-24

rolofylline and Anasarca

rolofylline has been researched along with Anasarca in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bloomfield, DM; Cleland, JG; Cotter, G; Davison, BA; Dittrich, HC; Edwards, C; Givertz, MM; Massie, BM; Metra, M; Milo, O; O'Connor, CM; Ponikowski, P; Senger, S; Teerlink, JR; Voors, AA1
Karasawa, A; Kusaka, H; Nagashima, K1

Other Studies

2 other study(ies) available for rolofylline and Anasarca

ArticleYear
Patient journey after admission for acute heart failure: length of stay, 30-day readmission and 90-day mortality.
    European journal of heart failure, 2016, Volume: 18, Issue:8

    Topics: Acute Disease; Aged; Comorbidity; Diabetes Mellitus; Disease Progression; Diuretics; Edema; Female; Heart Failure; Hospitalization; Humans; Length of Stay; Logistic Models; Male; Middle Aged; Mortality; Multivariate Analysis; Myocardial Ischemia; Odds Ratio; Patient Readmission; Proportional Hazards Models; Randomized Controlled Trials as Topic; Renal Insufficiency; Severity of Illness Index; Xanthines

2016
Effects of KW-3902, an adenosine A1-receptor antagonist, on ascites volume in puromycin aminonucleoside (PAN)-induced nephrotic rats.
    Japanese journal of pharmacology, 1995, Volume: 68, Issue:2

    Topics: Animals; Ascites; Diuretics; Edema; Furosemide; Male; Nephrosis; Purinergic P1 Receptor Antagonists; Puromycin Aminonucleoside; Rats; Rats, Wistar; Sodium Chloride Symporter Inhibitors; Trichlormethiazide; Xanthines

1995